In research published in Nature Medicine, Northwestern Medicine scientists have found a molecule that stops the growth of an aggressive pediatric brain tumor for which there is no current treatment.
Monthly Archives: February, 2017
Medical students in the Fein Yarns and Healing Threads student group work with patients at the Rehabilitation Institute of Chicago on their fine motor skills through knitting, and making baby hats for underserved patient populations.
A recent study, published in the New England Journal of Medicine, found a newer left ventricular assist device performed at least as well as existing devices on the market for patients with advanced heart failure.
Sandra Sanguino, ’93 MD, MPH, associate dean for Student Affairs, has received the Exceptional Mentor Award from the American Medical Women’s Association.
A phase 1 clinical trial of venetoclax and rituximab combination therapy was shown to be an effective chemo-free treatment option for patients with difficult-to-treat chronic lymphocytic leukemia.
A newly identified biomarker may predict treatment response in patients with chronic myelogenous leukemia, according to a Northwestern Medicine study.
Nearly 300 principal investigators gathered for a day of discussion and brainstorming to generate transformative ideas that will help guide the Feinberg research enterprise for the next five years.
As part of their community health project, first-year medical students presented on the barriers populations in different Chicago neighborhoods face to lead healthy lives.
Northwestern Medicine scientists identified the process by which a calcium channel called the CRAC channel opens and closes, and how mutations in the channel structures that control its opening cause disease.